Willkie Farr & Gallagher LLP

05/27/2025 | News release | Distributed by Public on 05/27/2025 09:10

Willkie Advises Sagard on Reinvestment in Sterimed as Part of Management-Led Consortium

News & Insights

Willkie Advises Sagard on Reinvestment in Sterimed as Part of Management-Led Consortium

News

share

May 27, 2025

Willkie advised Sagard on the sale of its majority stake in Sterimed Group, a leading provider of sterile medical packaging solutions, and its reinvestment in the company as part of a management-led consortium.

On May 22, Sterimed announced that it entered into an agreement to strengthen and reshuffle its capital base around its management team. Sagard, which, represented by Willkie, acquired a majority stake in Sterimed in 2019, invested in the company as part of consortium that includes the management team, IK Partners, and a club of new investors - Société Générale CP, Geneo CE, Capza and Investir pour l'Enfance - named "Friends of Sterimed."

Sagard Mid Cap is a French investment fund that provides equity capital to support the development of mid-sized companies led by ambitious teams.

The Willkie team was led by partners Christophe Garaud and Hugo Nocerino with associate Lafia Chaïb, and included partner Faustine Viala and associates Maud Boukhris and Hana Rousse.

Christophe Garaud Partner Corporate & Financial Services Paris [email protected] +33 1 53 43 45 13
Hugo Nocerino Partner Corporate & Financial Services Paris [email protected] +33 1 53 43 46 74
Lafia Chaïb Associate Corporate & Financial Services Paris [email protected] +33 1 53 43 4667
Faustine Viala Partner Antitrust & Competition Paris Brussels [email protected] +33 1 53 43 45 97
Maud Boukhris Associate Antitrust & Competition Paris [email protected] +33 1 53 43 45 15
Hana Rousse Associate Antitrust & Competition Paris [email protected] +33 1 53 43 4569

Related Practice Areas

Corporate & Financial Services Mergers & Acquisitions Private Equity Health Care & Life Sciences Manufacturing & Engineering

Related Locations

Paris

21 boulevard Malesherbes
75008 Paris

Willkie Farr & Gallagher LLP published this content on May 27, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 27, 2025 at 15:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]